Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus
Identifieur interne : 000803 ( PascalFrancis/Checkpoint ); précédent : 000802; suivant : 000804Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus
Auteurs : Katerina Venderov [Canada] ; Timothy M. Brown [Royaume-Uni] ; Jonathan M. Brotchie [Canada]Source :
- Experimental neurology : (Print) [ 0014-4886 ] ; 2005.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
In the globus pallidus, cannabinoid CB1 receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [3H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [3H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB1 receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [3H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:05-0317987Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Differential effects of endocannabinoids on [<sup>3</sup>H]-GABA uptake in the rat globus pallidus</title><author><name sortKey="Venderov, Katerina" sort="Venderov, Katerina" uniqKey="Venderov K" first="Katerina" last="Venderov">Katerina Venderov</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1><s2>Toronto, Ontario, M5T 258</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario, M5T 258</wicri:noRegion></affiliation></author><author><name sortKey="Brown, Timothy M" sort="Brown, Timothy M" uniqKey="Brown T" first="Timothy M." last="Brown">Timothy M. Brown</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>School of Biological Sciences, University of Manchester</s1><s2>Manchester</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region><settlement type="city">Manchester</settlement></placeName><orgName type="university">Université de Manchester</orgName></affiliation></author><author><name sortKey="Brotchie, Jonathan M" sort="Brotchie, Jonathan M" uniqKey="Brotchie J" first="Jonathan M." last="Brotchie">Jonathan M. Brotchie</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1><s2>Toronto, Ontario, M5T 258</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario, M5T 258</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0317987</idno><date when="2005">2005</date><idno type="stanalyst">PASCAL 05-0317987 INIST</idno><idno type="RBID">Pascal:05-0317987</idno><idno type="wicri:Area/PascalFrancis/Corpus">000901</idno><idno type="wicri:Area/PascalFrancis/Curation">000422</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000803</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000803</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Differential effects of endocannabinoids on [<sup>3</sup>H]-GABA uptake in the rat globus pallidus</title><author><name sortKey="Venderov, Katerina" sort="Venderov, Katerina" uniqKey="Venderov K" first="Katerina" last="Venderov">Katerina Venderov</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1><s2>Toronto, Ontario, M5T 258</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario, M5T 258</wicri:noRegion></affiliation></author><author><name sortKey="Brown, Timothy M" sort="Brown, Timothy M" uniqKey="Brown T" first="Timothy M." last="Brown">Timothy M. Brown</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>School of Biological Sciences, University of Manchester</s1><s2>Manchester</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region><settlement type="city">Manchester</settlement></placeName><orgName type="university">Université de Manchester</orgName></affiliation></author><author><name sortKey="Brotchie, Jonathan M" sort="Brotchie, Jonathan M" uniqKey="Brotchie J" first="Jonathan M." last="Brotchie">Jonathan M. Brotchie</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1><s2>Toronto, Ontario, M5T 258</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Toronto, Ontario, M5T 258</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Experimental neurology : (Print)</title><title level="j" type="abbreviated">Exp. neurol. : (Print)</title><idno type="ISSN">0014-4886</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Experimental neurology : (Print)</title><title level="j" type="abbreviated">Exp. neurol. : (Print)</title><idno type="ISSN">0014-4886</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term><term>Basal ganglion</term><term>CB1 cannabinoid receptor</term><term>Cannabinoid</term><term>GABA</term><term>Gabaergic neuron</term><term>Glycerol</term><term>Parkinson disease</term><term>Rat</term><term>Uptake</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term><term>Cannabinoïde</term><term>GABA</term><term>Captation</term><term>Animal</term><term>Rat</term><term>Récepteur cannabinoïde CB1</term><term>Neurone gabaergique</term><term>Glycérol</term><term>Noyau gris central</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the globus pallidus, cannabinoid CB<sub>1</sub> receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [<sup>3</sup>H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [<sup>3</sup>H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB<sub>1</sub> receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [<sup>3</sup>H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0014-4886</s0></fA01><fA02 i1="01"><s0>EXNEAC</s0></fA02><fA03 i2="1"><s0>Exp. neurol. : (Print)</s0></fA03><fA05><s2>194</s2></fA05><fA06><s2>1</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Differential effects of endocannabinoids on [<sup>3</sup>H]-GABA uptake in the rat globus pallidus</s1></fA08><fA11 i1="01" i2="1"><s1>VENDEROV (Katerina)</s1></fA11><fA11 i1="02" i2="1"><s1>BROWN (Timothy M.)</s1></fA11><fA11 i1="03" i2="1"><s1>BROTCHIE (Jonathan M.)</s1></fA11><fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1><s2>Toronto, Ontario, M5T 258</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ></fA14><fA14 i1="02"><s1>School of Biological Sciences, University of Manchester</s1><s2>Manchester</s2><s3>GBR</s3><sZ>2 aut.</sZ></fA14><fA20><s1>284-287</s1></fA20><fA21><s1>2005</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>9181</s2><s5>354000124651760240</s5></fA43><fA44><s0>0000</s0><s1>© 2005 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>25 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>05-0317987</s0></fA47><fA60><s1>P</s1><s3>CC</s3></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Experimental neurology : (Print)</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>In the globus pallidus, cannabinoid CB<sub>1</sub> receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [<sup>3</sup>H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [<sup>3</sup>H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB<sub>1</sub> receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [<sup>3</sup>H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease.</s0></fC01><fC02 i1="01" i2="X"><s0>002B16B</s0></fC02><fC02 i1="02" i2="X"><s0>002B17G</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Cannabinoïde</s0><s5>09</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Cannabinoid</s0><s5>09</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Canabinoide</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>GABA</s0><s2>NK</s2><s5>10</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>GABA</s0><s2>NK</s2><s5>10</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>GABA</s0><s2>NK</s2><s5>10</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Captation</s0><s5>11</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Uptake</s0><s5>11</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Captación</s0><s5>11</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Animal</s0><s5>12</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Animal</s0><s5>12</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Animal</s0><s5>12</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Rat</s0><s5>13</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Rat</s0><s5>13</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Rata</s0><s5>13</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Récepteur cannabinoïde CB1</s0><s5>14</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>CB1 cannabinoid receptor</s0><s5>14</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Receptor canabinoide CB1</s0><s5>14</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Neurone gabaergique</s0><s5>15</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Gabaergic neuron</s0><s5>15</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Neurona gabaminérgica</s0><s5>15</s5></fC03><fC03 i1="09" i2="X" l="FRE"><s0>Glycérol</s0><s2>NK</s2><s2>FR</s2><s5>16</s5></fC03><fC03 i1="09" i2="X" l="ENG"><s0>Glycerol</s0><s2>NK</s2><s2>FR</s2><s5>16</s5></fC03><fC03 i1="09" i2="X" l="SPA"><s0>Glicerol</s0><s2>NK</s2><s2>FR</s2><s5>16</s5></fC03><fC03 i1="10" i2="X" l="FRE"><s0>Noyau gris central</s0><s5>17</s5></fC03><fC03 i1="10" i2="X" l="ENG"><s0>Basal ganglion</s0><s5>17</s5></fC03><fC03 i1="10" i2="X" l="SPA"><s0>Núcleo basal</s0><s5>17</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Rodentia</s0><s2>NS</s2></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Rodentia</s0><s2>NS</s2></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Rodentia</s0><s2>NS</s2></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0><s2>NS</s2></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Mammalia</s0><s2>NS</s2></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Mammalia</s0><s2>NS</s2></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0><s2>NS</s2></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Vertebrata</s0><s2>NS</s2></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Vertebrata</s0><s2>NS</s2></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Neurotransmetteur</s0><s5>37</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Neurotransmitter</s0><s5>37</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Neurotransmisor</s0><s5>37</s5></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Encéphale pathologie</s0><s5>38</s5></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>38</s5></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>38</s5></fC07><fC07 i1="06" i2="X" l="FRE"><s0>Système nerveux central</s0><s5>39</s5></fC07><fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system</s0><s5>39</s5></fC07><fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervioso central</s0><s5>39</s5></fC07><fC07 i1="07" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0><s5>40</s5></fC07><fC07 i1="07" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>40</s5></fC07><fC07 i1="07" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>40</s5></fC07><fC07 i1="08" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>41</s5></fC07><fC07 i1="08" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>41</s5></fC07><fC07 i1="08" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>41</s5></fC07><fC07 i1="09" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0><s5>42</s5></fC07><fC07 i1="09" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>42</s5></fC07><fC07 i1="09" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>42</s5></fC07><fC07 i1="10" i2="X" l="FRE"><s0>Système nerveux pathologie</s0><s5>43</s5></fC07><fC07 i1="10" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>43</s5></fC07><fC07 i1="10" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>43</s5></fC07><fN21><s1>220</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>Canada</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Manchester</li></region><settlement><li>Manchester</li></settlement><orgName><li>Université de Manchester</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Venderov, Katerina" sort="Venderov, Katerina" uniqKey="Venderov K" first="Katerina" last="Venderov">Katerina Venderov</name></noRegion><name sortKey="Brotchie, Jonathan M" sort="Brotchie, Jonathan M" uniqKey="Brotchie J" first="Jonathan M." last="Brotchie">Jonathan M. Brotchie</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Brown, Timothy M" sort="Brown, Timothy M" uniqKey="Brown T" first="Timothy M." last="Brown">Timothy M. Brown</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000803 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000803 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:05-0317987
|texte= Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus
}}
| This area was generated with Dilib version V0.6.29. |  |